Global Pharma Handbook 2025 Covers 70+ Countries & Regulatory Insights
Dublin, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The "Global Pharma Handbook 2025" has been added to ResearchAndMarkets.com's offering.
The fully revised and expanded Global Pharma Handbook provides pharmaceutical industry decision-makers with a unique source of accurate, up-to-date information and analysis on prescription drug business and regulatory environments throughout the world. Coverage of over 70 individual countries (cumulatively representing more than 97% of global sales) and a summary section on the EU are included.
Company executives, consultants, marketing and licensing partners, policymakers, researchers, investors, reporters, and others who work with the pharmaceutical industry will benefit from the Global Pharma Handbook.
Whether you're working on a cutting-edge specialty drug or a mature generic, whether your drug is on the market or still in clinical trials, the Global Pharma Handbook is a thorough, data-rich report that gives you insight into the structures, trends, and regulations driving eight of the world's most important pharmaceutical markets.
Information for 70 countries on:
- Approval Procedures Branded vs Generic Use Clinical Trial Regulations and Practices Distribution Systems Drug Regulatory Agencies and Policies Generic Regulations and Market Trends Growth Rates Healthcare Systems Intellectual Property & Parallel Trade Issues Intellectual Property Regulations and Practices Manufacturing Infrastructure Marketing Regulations and Practices Payment Patterns Pharmaceutical Market Forecasts Pharmaceutical Market Structure Population & Prescriber Characteristics Pricing Regulations Public and Private Payment and Reimbursement Systems R&D Incentives Regulatory Bodies Research, Distribution & Marketing Sales & Consumption Sales Channels Trade Policies
Market Coverage (Including updated contact information for all countries):
- European Union: All 28 countries Europe (Non-EU): Norway Russia, Switzerland, Ukraine Asia Pacific: Australia, China, India, Indonesia, Japan, Korea, Malaysia, New Zealand, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam Latin America: Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, Peru Middle East: Bahrain, Egypt, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, Turkey, UAE Africa: Kenya, Nigeria, Tanzania, South Africa, Uganda North America: Canada, United States
The Global Pharma Handbook is a trusted and increasingly valuable resource. The current edition includes expanded coverage of health systems, recent and forecast pharmaceutical sales, market demand profiles, clinical trial, and drug approval procedures, regulatory policies, pricing and reimbursement regulations, intellectual property issues, sales and marketing practices, distribution networks, political risks, patient and prescriber characteristics, policies on branded and generic use, clinical research activity and other key factors.
Key Topics Covered:
- EU Pharmaceutical Regulations Gulf States Pharmaceutical Regulations Latin American Pharmaceutical Regulations Pharmaceutical Country Profiles & Regulations Globally Medicines Regulatory Authorities Country Specific Clinical Study Requirements Health at a Glance: OECD Indicators
For more information about this directory visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment